SEC Form 4 · accession 0001493152-18-003653
Bone Biologics Corp · BBLG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Deina H Walsh
Officer — Chief Financial Officer
Period of report
Feb 16, 2018
Accepted (ET)
Mar 20, 2018 · 4:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001419554
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1 | $0.00 | Feb 16, 2018 | A | 28,426 | A | — | — | Common Stock | 28,426 | 39,530 | D |
Explanation of responses
- F1On February 16, 2018, the Reporting Person was granted 28,426 shares of restricted stock units which will become fully vested 2 years from the grant date on February 16, 2020, provided the Reporting Person is still providing services to the issuer on the respective date.